Affimed struck a game-changing deal with Roche yesterday, causing its shares to sky-rocket."Up 246%: Is This Small-Cap Biotech Stock Still a Buy?" via FOX BIZ https://ift.tt/2BYyRd1
Subscribe to:
Post Comments (Atom)
Popular posts
-
This July, software grandee John McAfee donned the fool’s cap… and brought down roars of laughter upon his head… This bedlamite actuall...
-
Tesla drivers who engage the Autopilot feature should recognize that it requires the assistance of the driver, a cybersecurity expert told ...
No comments:
Post a Comment